The Beatson West of Scotland Cancer Centre (WoSCC), is seeking to appoint a Consultant Clinical Oncologist with special interest in Breast cancers.

The Beatson West of Scotland Cancer Centre (BWoSCC) opened in May 2007, completing a state of the art comprehensive cancer centre that has cost £110 million. It is Scotlands largest cancer centre, and the second largest in the UK. The centre has undergone unprecedented investment and our clinical teams deliver oncology services to a catchment population of 2.9 million people across 4 Health Board areas. The centre is part of the CRUK virtual comprehensive cancer treatment and research centre which also includes the Beatson Institute for Cancer Research and soon to be built Translational Research Centre. It incorporates the Regional Haemato-oncology Autologous Transplant Unit and the National Allogeneic Transplant Service for haematological malignancies.

The equipment in the new centre is state-of-the-art, and includes 11 linear accelerators with on board imaging, and incorporates Image Guided Radiotherapy (IGRT), IMRT, and Stereotactic Radiotherapy into our portfolio of available technologies. The centre uses VMAT technology to more effectively deliver IMRT. A completely new brachytherapy unit and programme has been established in the centre. A state of the art satellite centre opened on the Monklands hospital site in Lanarkshire in November 2015.This was conceived and delivered to specifically address radiotherapy capacity issues with the added benefit of local radiotherapy delivery.This facility provides a further 2 LINACS fully integrated with the parent site.

The Beatson is an internationally renowned academic centre, with Professors of Medical Oncology, Clinical Oncology, Translational Research and Palliative Care currently in post.

The Beatson West of Scotland Cancer Centre Clinical research unit is the largest of its kind to be funded by Cancer Research UK. The unit offers support to all clinicians within the BWoSCC to initiate and conduct first-in man clinical trials. The unit has a large portfolio of Phase I-III studies across the range of cancer sub-specialties and has a particular interest in the development of new anti-cancer drugs, supported by designated staff and facilities for Phase I/early Phase II clinical trials. The unit also houses Scotlands first ever co-ordinating centre for the National Cancer Research Institute.

For further details of the posts please contact:

The Clinical Director, Dr. Ioanna Nixon +44 (0)141 301 7088, e-mail ioanna.nixon@ggc.scot.nhs.uk

Applicants should have full GMC registration, and or eligibility to be included on the Specialist Register. UK trainees will have evidence of Higher Specialist Training leading to CCT, or be within six months of confirmed entry from the date of interview. Non-UK applicants must demonstrate equivalent training.

Interview Date: 15/07/2024

You can also visit our website: www.beatson.org.uk

(Please note the salary is Pro Rata) for part time hours.

Details on how to contact the Recruitment Service can be found within the Candidate Information Packs.

NHS Greater Glasgow and Clyde encourages applications from all sections of the community. We promote a culture of inclusion across the organisation and are proud of the diverse workforce we have.

By signing the Armed Forces Covenant, NHSGGC has pledged its commitment to being a Forces Friendly Employer. We support applications from across the Armed Forces Community, recognising military skills, experience and qualifications during the recruitment and selection process.

For application portal/log-in issues, please contact Jobtrain support hub in the first instance.